Stanciu Mihaela, Sima Oana-Claudia, Costachescu Mihai, Valea Ana, Nistor Claudiu, Trandafir Alexandra-Ioana, Tanasescu Denisa, Nistor Tiberiu Vasile Ioan, Ciobica Mihai-Lucian, Carsote Mara
Department of Endocrinology, "Lucian Blaga" University of Sibiu, Victoriei Blvd., 550024 Sibiu, Romania.
Department of Endocrinology, Clinical County Emergency Hospital, 550245 Sibiu, Romania.
J Clin Med. 2025 Mar 27;14(7):2302. doi: 10.3390/jcm14072302.
Osteoporotic fractures may be prevalent, as expected, in patients with primary osteoporosis such as menopause-related or age-related bone loss, but a supplementary contribution to the risk may be added by less than common conditions, including a non-functioning adrenal tumor with or without mild autonomous cortisol secretion (MACS). Many of the standard fracture risk-related elements are captured by the FRAX model; yet, novel insights are brought by an improved algorithm, namely, FRAXplus. Our objective was to analyze the fracture risk in menopausal females diagnosed with low bone mineral density (BMD) and MACS-negative adrenal incidentalomas using FRAXplus (lumbar BMD adjustment). This as a retrospective, multi-center study of 66 menopausal women, where 50% of them had non-MACS adrenal tumors (group A), and 33 were controls (group B). They were put into four sub-groups, either group A1 (N = 14/33 subjects with normal DXA), or A2 (19/33 subjects with lowest T-score < -1), or group B1 (14/33) where subjects had normal DXA, or group B2 (19/33) for subjects with low BMD. The sub-groups were matched on age, body mass index, and years since menopause, as well BMD matched (A versus B, A1 versus B1, A2 versus B2). FRAX analysis showed similar results for 10-year probability between groups A and B, and A2 and B2, while lumbar BMD adjustment showed statistically significant lower risk in group A1 versus B1 ( = 0.013), but not for hip fracture ( = 0.064). we introduced a pilot study in the FRAXplus model regarding adrenal tumors diagnosed in menopausal females with or without low BMD at central DXA assessment, a pilot study that to the best of our knowledge represents the first of this kind due to the novelty of using this fracture risk calculator with lumbar BMD adjustment. FRAXplus algorithm might be a better discriminator for fracture risk in these patients since we found that in age-, BMI-, and years since menopause-matched sub-groups, patients with normal DXA and MACS-free adrenal incidentalomas display a lower 10-year probability of major osteoporotic fractures than controls upon lumbar BMD adjustment.
正如预期的那样,骨质疏松性骨折在患有原发性骨质疏松症的患者中很常见,例如与绝经相关或与年龄相关的骨质流失,但一些不太常见的情况可能会增加骨折风险,包括伴有或不伴有轻度自主性皮质醇分泌(MACS)的无功能肾上腺肿瘤。许多与骨折风险相关的标准因素都被FRAX模型所涵盖;然而,一种改进的算法,即FRAXplus,带来了新的见解。我们的目的是使用FRAXplus(腰椎骨密度调整)分析诊断为低骨矿物质密度(BMD)和MACS阴性肾上腺偶发瘤的绝经后女性的骨折风险。这是一项对66名绝经后女性进行的回顾性多中心研究,其中50%的女性患有非MACS肾上腺肿瘤(A组),33名作为对照(B组)。她们被分为四个亚组,即A1组(N = 14/33,双能X线吸收法(DXA)正常的受试者),或A2组(19/33,最低T值<-1的受试者);或者B1组(14/33),该组受试者DXA正常,或者B2组(19/33),该组受试者骨密度低。这些亚组在年龄、体重指数和绝经后的年限方面进行了匹配,骨密度也进行了匹配(A组与B组、A1组与B1组、A2组与B2组)。FRAX分析显示,A组和B组以及A2组和B2组之间10年骨折概率的结果相似,而腰椎骨密度调整显示A1组与B1组相比骨折风险在统计学上显著降低(P = 0.013),但髋部骨折风险没有显著差异(P = 0.064)。我们在FRAXplus模型中针对在中央DXA评估中诊断为有或无低骨密度的绝经后女性肾上腺肿瘤开展了一项初步研究,据我们所知,由于使用这种带有腰椎骨密度调整的骨折风险计算器具有新颖性,该初步研究是同类研究中的首例。我们发现,在年龄、体重指数和绝经后年限匹配的亚组中,DXA正常且无MACS的肾上腺偶发瘤患者在进行腰椎骨密度调整后,10年发生主要骨质疏松性骨折的概率低于对照组,因此FRAXplus算法可能是这些患者骨折风险的更好判别方法。